Crossmark

Efficacy and safety of neoadjuvant chemoimmunotherapy in elderly patients with resectable non-small cell lung cancer: a network meta-analysis and systematic review

Crossref DOI link: https://doi.org/10.1007/s44178-025-00193-1

Published Online: 2025-09-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Yufeng https://orcid.org/0009-0007-5881-3249
Yang, Pirong https://orcid.org/0009-0004-6131-3008
Feng, Qiwei https://orcid.org/0009-0009-6129-7817
Li, Juan https://orcid.org/0000-0002-1617-3294
Funding

Funding for this research was provided by:

Sichuan Province Science and Technology Support Program (2024YFHZ0143)
License Information

Text and Data Mining valid from 2025-09-24

Version of Record valid from 2025-09-24
More Information

Article History

Received: 25 March 2025

Revised: 8 August 2025

Accepted: 13 August 2025

First Online: 24 September 2025

Declarations

:

: Not applicable. Informed consent was obtained from all participants.

: Written consent to publish this review was obtained from each study participant.

: Author declares no conflict of interest.

Document is current

Any future updates will be listed below